不同外用糖皮质激素效力分类系统之间的一致性与相关性
该分类研究从文献、安大略省药物福利目录、近期Cochrane综述和WHO的ATC分类中汇编232种外用糖皮质激素制剂,分别按美国7类系统、Cochrane综述4类系统和ATC 4类系统划分效力并比较一致性。结果显示各系统间一致性低至中等但相关性较强,提示不同分类系统在药物流行病学研究中可能得出不同结果。
要点
- 研究纳入232种外用糖皮质激素制剂,分别用美国7类、Cochrane综述4类和ATC 4类系统分类。
- 美国分类与ATC系统一致性弱(κw=0.53),与Cochrane综述分类一致性中等(κw=0.60)。
- 各分类系统间相关性较强(r=0.71至0.77),但一致性仅低至中等。
核心结论
- 由于不同效力分类系统常不一致,在药物流行病学研究中可能得出不同结果,研究者应透明报告分类方法并在敏感性分析中考虑替代效力定义。
研究设计与样本
- 分类研究,从文献、安大略省药物福利目录、近期Cochrane综述和WHO的ATC分类中汇编外用糖皮质激素制剂清单,时间范围为2021年8月11日至2022年1月6日。
- 共纳入232种独特外用糖皮质激素制剂(ATC分类n=231;美国分类n=232;Cochrane综述n=89)。
- 使用美国7类分类系统、主要基于英国目录的Cochrane综述4类分类系统和ATC 4类分类系统进行效力分类并比较,为便于跨系统比较将美国7类系统合并为4类。
主要发现
- 美国分类与ATC系统一致性弱(κw=0.53;95%CI 0.45-0.60),与Cochrane综述分类一致性中等(κw=0.60;95%CI 0.48-0.73)。
- ATC与Cochrane综述分类之间一致性弱(κw=0.58;95%CI 0.46-0.71)。
- 美国分类与ATC系统相关性较强(r=0.77;95%CI 0.71-0.82),与Cochrane综述分类相关性较强(r=0.74;95%CI 0.62-0.82)。
- Cochrane综述与ATC分类之间相关性较强(r=0.71;95%CI 0.58-0.80)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Topical corticosteroids (TCSs) are available in multiple potencies that alter their effectiveness and safety. Pharmacoepidemiologic studies on TCSs are hampered by the absence of a universal potency classification system, limiting comparisons across studies, robust exposure classification, and clinical interpretation. OBJECTIVE: To classify TCSs into 3 commonly used potency classification systems and evaluate the agreement and correlation between the 3 systems. DESIGN, SETTING, AND PARTICIPANTS: In this classification study, a comprehensive list of TCS formulations was compiled using sources identified in the literature, the Ontario Drug Benefit Formulary, a recent Cochrane review on the use of TCSs in people with eczema, and the Anatomical Therapeutic Classification (ATC) of the World Health Organization from August 11, 2021, to January 6, 2022. Topical corticosteroid potency classifications were assigned and compared using the 7-category US classification system, a 4-category classification from a recent Cochrane review largely based on the UK formulary, and the 4-category ATC classification. To facilitate comparisons across systems, the 7-category US system was consolidated into 4 categories. MAIN OUTCOMES AND MEASURES: Cohen weighted κ (κw) and Spearman rank correlation coefficients (r) were computed to examine agreement and correlation between the classification systems. RESULTS: A total of 232 unique TCS formulations (ATC, n = 231; US classification, n = 232; Cochrane review, n = 89) were included. Overall, there was low-to-moderate agreement but strong correlation between the classification systems. The US classification had weak agreement with the ATC system (κw, 0.53; 95% CI, 0.45-0.60) and moderate agreement with the Cochrane review classification (κw, 0.60; 95% CI, 0.48-0.73); there was weak agreement between the ATC and Cochrane review classifications (κw, 0.58; 95% CI, 0.46-0.71). The US classification strongly correlated with the ATC system (r, 0.77; 95% CI, 0.71-0.82) and Cochrane review classification (r, 0.74; 95% CI, 0.62-0.82). There was also a strong correlation between the Cochrane review and ATC classifications (r, 0.71; 95% CI, 0.58-0.80). CONCLUSIONS AND RELEVANCE: This classification study used multiple resources to classify 232 TCS formulations into 3 potency classifications. Because these systems are often incongruent, they may yield different results in pharmacoepidemiologic studies; investigators need to be transparent in their classification approach and consider alternative potency definitions in sensitivity analyses.
引用
- Bowie AC, Tadrous M, Egeberg A, et al. Agreement and Correlation Between Different Topical Corticosteroid Potency Classification Systems. JAMA Dermatol. 2022. PMID: 35612864. doi:10.1001/jamadermatol.2022.1706
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。